Lenacapavir(GS-6207) is a first-in-class, long-acting HIV capsid inhibitor. Lenacapavir has anti-HIV activity with an EC50 of 100 pM in MT-4 cells and a mean EC50 of 50 pM (20-160 pM) against 23 clinical isolates of HIV-1 from different subtypes in peripheral blood mononuclear cells.
Molekulargewicht:
968.28
Reinheit:
>98%
CAS Nummer:
[2189684-44-2]
Formel:
C39H32ClF10N7O5S2
Target-Kategorie:
HIV Protease
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten